Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
53pct
15d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Opioid Program Evaluation Act or the OPEN Act (Sec. 2) This bill directs the Department of Justice (DOJ) to enter into an arrangement with the National Academy of Sciences (NAS) to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of a DOJ grant program to provide opioid abuse services. DOJ must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations. (Sec. 3) Additionally, the bill directs the Department of Health and Human Services (HHS) to enter into an arrangement with the NAS to identify outcomes and develop metrics to evaluate: (1) the incidence of opioid abuse and illegal opioid distribution, and (2) the effectiveness of HHS grant programs to address opioid abuse. HHS must publish outcomes and metrics and require grant recipients to collect and report data. The NAS must publish the evaluations. (Sec. 6) It amends the Justice Assistance Act of 1984 to reduce for FY2022 the authorization of appropriation for financial assistance under the Emergency Federal Law Enforcement Assistance program.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · fourth_quarter · Pharmacy
Legislation and policies relating to: H.R. 471/S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act H.R. 953/S. 524 - Comprehensive Addiction and Recovery Act of 2015 H.R. 2536/S. 1455 - Recovery Enhancement for Addiction Treatment (TREAT) Act H.R. 4435 - Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R. 4843 - Infant Plan of Safe Care Improvement Act H.R. 4978 - NAS Healthy Babies Act H.R. 4981 - Opioid Use Disorder Treatment Expansion and Modernization Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R. 5052 - Opioid Program Evaluation Act S. 1392 - Safe Prescribing of Controlled Substances Act S. 2423 - A bill making appropriations to address the heroin and opioid drug abuse epidemic for the fiscal year ending September 30, 2016, and for other purposes S. 3075 - Addiction Prevention and Responsible Opioid Practices Act S. 3223 - Expanded Access to Treatment and Recovery Act
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 1 (Roll no. 181). (text: CR H2181-2182)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 1 (Roll no. 181).(text: CR H2181-2182)
HouseConsidered as unfinished business. (consideration: CR H2193-2194)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 5052.
Considered under suspension of the rules. (consideration: CR H2181-2184)
Mr. Goodlatte moved to suspend the rules and pass the bill, as amended.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Health Issues
Opioid response and recovery S. 524, H.R. 5046, H.R. 5052, 21st Century Cures Act
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Office on Violence Against Women, SENATE
2016 · third_quarter · Pharmacy
Legislation and policies relating to: H.R. 471/S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act H.R. 953/S. 524 - Comprehensive Addiction and Recovery Act of 2015 H.R. 2536/S. 1455 - Recovery Enhancement for Addiction Treatment (TREAT) Act H.R. 4435 - Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R. 4843 - Infant Plan of Safe Care Improvement Act H.R. 4978 - NAS Healthy Babies Act H.R. 4981 - Opioid Use Disorder Treatment Expansion and Modernization Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R. 5052 - Opioid Program Evaluation Act S. 1392 - Safe Prescribing of Controlled Substances Act S. 2423 - A bill making appropriations to address the heroin and opioid drug abuse epidemic for the fiscal year ending September 30, 2016, and for other purposes S. 3075 - Addiction Prevention and Responsible Opioid Practices Act S. 3223 - Expanded Access to Treatment and Recovery Act
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Health Issues
Opioid response and recovery S. 524, H.R. 5046, H.R. 5052
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Office on Violence Against Women, SENATE
2016 · second_quarter · Pharmacy
Legislation and policies relating to: H.R. 471/S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act H.R. 953/S. 524 - Comprehensive Addiction and Recovery Act of 2015 H.R. 2536/S. 1455 - Recovery Enhancement for Addiction Treatment (TREAT) Act H.R. 4435 - Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R. 4843 - Infant Plan of Safe Care Improvement Act H.R. 4978 - NAS Healthy Babies Act H.R. 4981 - Opioid Use Disorder Treatment Expansion and Modernization Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R. 5052 - Opioid Program Evaluation Act S. 1392 - Safe Prescribing of Controlled Substances Act S. 2423 - A bill making appropriations to address the heroin and opioid drug abuse epidemic for the fiscal year ending September 30, 2016, and for other purposes S. 3075 - Addiction Prevention and Responsible Opioid Practices Act
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · second_quarter · Health Issues
Opioid response and recovery S. 524, H.R. 5046, H.R. 5052
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Office on Violence Against Women, SENATE
2016 · second_quarter · Health Issues
S. 1945, Mental Health Reform Act of 2015, all provisions H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions H.R. 2536, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions S. 1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions H.R. 1725, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015, all provisions S. 480, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2016, all provisions H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016, all provisions S. 524, Comprehensive Addiction and Recovery Act of 2016, all provisions H.R. 4586, Lali's Law, all provisions H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 6, 21st Century Cures Act, provisions relating to transparency reporting, all provisions S. 2978, Protect Continuing Physician Education and Patient Care Act, all provisions S. 3077, Marijuana Effective Drug Studies (MEDS) Act of 2016, all provisions H.R. 5395, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions S. 2873, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions S. 779, Fair Access to Science and Technology Research Act of 2015, all provisions H.R. 4641, To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes, all provisions H.R. 4063, Jason Simcakoski PROMISE Act, all provisions H.R. 4969, John Thomas Decker Act of 2016, all provisions H.R. 4985, Kingpin Designation Improvement Act of 2016, all provisions H.R. 5052, Opioid Program Evaluation (OPEN) Act, all provisions H.R. 4843, Infant Plan of Safe Care Improvement Act, all provisions H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2016, all provisions H.R. 4978, Nurturing And Supporting Healthy Babies Act, all provisions H.R. 3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, all provisions H.R. 4599, Reducing Unused Medications Act of 2016, all provisions H.R. 4976, Opioid Review Modernization Act of 2016, all provisions H.R. 4982, Examining Opioid Treatment Infrastructure Act of 2016, all provisions H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization Act, all provisions Prescription Drug Diversion Opioid Abuse/Medication assisted treatment 21st Century Cures/Innovations Zika Funding Laboratory Developed Tests (LDT) Guidance Telemedicine - Interstate Medical Licensure Compact Health data security Gun violence research/background checks funding Sexual violence EHR/Meaningful Use Sunshine Act Health Savings Accounts - Prescription requirements for over-the-counter medications Prediabetes coverage Blood pressure monitoring coverage Compounding PrecisionFDA Clinical trials - insurance coverage improvement HIPAA Regulations Dietary supplements EHR/Interoperability Diabetes Prevention Program (DPP) fees
Placed on the Union Calendar, Calendar No. 417.
Committee on Energy and Commerce discharged.
Committee on Energy and Commerce discharged.
Reported by the Committee on Judiciary. H. Rept. 114-541, Part I.
Congress.gov source codes: 5000, H12200
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Markup by |
| April 27, 2016 |
| Energy and Commerce Committee | House | Referred to | April 26, 2016 |
| Judiciary Committee | House | Referred to | April 26, 2016 |
| April 26, 2016 |
Client expense: $4,310,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA), White House Office